183 related articles for article (PubMed ID: 37152024)
1. Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells.
Gehre S; Meyer F; Sengedorj A; Grottker F; Reichardt CM; Alomo J; Borgmann K; Frey B; Fietkau R; Rückert M; Gaipl US
Front Oncol; 2023; 13():981239. PubMed ID: 37152024
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells.
Sengedorj A; Hader M; Heger L; Frey B; Dudziak D; Fietkau R; Ott OJ; Scheidegger S; Barba SM; Gaipl US; Rückert M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565180
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells.
Wimmer S; Deloch L; Hader M; Derer A; Grottker F; Weissmann T; Hecht M; Gostian AO; Fietkau R; Frey B; Gaipl US
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502022
[TBL] [Abstract][Full Text] [Related]
4. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells.
Grottker F; Gehre S; Reichardt CM; Sengedorj A; Jost T; Rieckmann T; Hecht M; Gostian AO; Frey B; Fietkau R; Gaipl US; Rückert M
Neoplasia; 2023 Nov; 45():100944. PubMed ID: 37857049
[TBL] [Abstract][Full Text] [Related]
6. Detailed
Stoll E; Hader M; Rückert M; Weissmann T; Lettmaier S; Putz F; Hecht M; Fietkau R; Rosin A; Frey B; Gaipl US
Int J Hyperthermia; 2022; 39(1):796-805. PubMed ID: 35676615
[TBL] [Abstract][Full Text] [Related]
7. The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation.
Kötter B; Frey B; Winderl M; Rubner Y; Scheithauer H; Sieber R; Fietkau R; Gaipl US
Radiat Oncol; 2015 Sep; 10():197. PubMed ID: 26383236
[TBL] [Abstract][Full Text] [Related]
8. Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy.
Hader M; Savcigil DP; Rosin A; Ponfick P; Gekle S; Wadepohl M; Bekeschus S; Fietkau R; Frey B; Schlücker E; Gaipl US
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349284
[TBL] [Abstract][Full Text] [Related]
9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
[TBL] [Abstract][Full Text] [Related]
11. CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models.
Cheung A; Chenoweth AM; Quist J; Sow HS; Malaktou C; Ferro R; Hoffmann RM; Osborn G; Sachouli E; French E; Marlow R; Lacy KE; Papa S; Grigoriadis A; Karagiannis SN
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884422
[TBL] [Abstract][Full Text] [Related]
12. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
13. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
Frey B; Rückert M; Weber J; Mayr X; Derer A; Lotter M; Bert C; Rödel F; Fietkau R; Gaipl US
Front Immunol; 2017; 8():231. PubMed ID: 28337197
[TBL] [Abstract][Full Text] [Related]
15. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
[TBL] [Abstract][Full Text] [Related]
16. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
Li J; Zhang D; Liu Z; Wang Y; Li X; Wang Z; Liang G; Yuan X; Li Y; Komorowski AL; Rozen WM; Orlandi A; Takabe K; Franceschini G; Jerusalem G; Wang X
Ann Transl Med; 2023 Jan; 11(2):83. PubMed ID: 36819490
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines.
Bräutigam K; Kabore-Wolff E; Hussain AF; Polack S; Rody A; Hanker L; Köster F
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2923-2933. PubMed ID: 34185141
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiles Induced by High-dose Ionizing Radiation in MDA-MB-231 Triple-negative Breast Cancer Cell Line.
Bravatà V; Cammarata FP; Minafra L; Musso R; Pucci G; Spada M; Fazio I; Russo G; Forte GI
Cancer Genomics Proteomics; 2019; 16(4):257-266. PubMed ID: 31243106
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.
Lee H; To NB; Kim M; Nguyen YT; Cho SK; Choi HK
J Pharm Biomed Anal; 2022 Jan; 208():114449. PubMed ID: 34749107
[TBL] [Abstract][Full Text] [Related]
20. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
